Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated Sep 6, 2024
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Apogee Therapeutics, Inc.
| -40.00K |
$47.62 | -$1,904,841.05 | -2.79% | 1.39M |
Sep 4
|
Scheduled
| ||||||
Apogee Therapeutics, Inc.
| -40.00K |
$40.62 | -$1,624,764.04 | -2.71% | 1.43M |
Aug 7
|
Scheduled
| ||||||
Arya Sciences Acquisition Corp IV
|
0
|
—
|
—
|
—
|
0
|
Jul 31
| |||||||
Apogee Therapeutics, Inc.
| -15.00K |
$37.26 | -$558,900.00 | -1.01% | 1.47M |
Jul 5
|
Scheduled
| ||||||
Spyre Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
May 14
| |||||||
Apogee Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Dec 18
| |||||||
Apogee Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Apogee Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Aeglea Biotherapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Arya Sciences Acquisition Corp IV
|
0
|
—
|
—
|
—
|
0
| ||||||||
Bridgebio Pharma, Inc.
|
0
|
—
|
—
|
—
|
0
|
Dec 15
| |||||||
Bridgebio Pharma, Inc.
|
0
|
$26.29 | -$504,704.08 |
—
| 274.21K |
Dec 1
|
Scheduled
| ||||||
Bridgebio Pharma, Inc.
| -784.00 |
$30.04 | -$23,548.54 | -0.30% | 261.4K |
Jun 3
|
Scheduled
| ||||||
Bridgebio Pharma, Inc.
| 6.46K |
$22.90 | -$731,628.49 | +2.41% | 274.21K |
Nov 16
|
Scheduled
| ||||||
Bridgebio Pharma, Inc.
|
0
|
$19.70 | -$373,057.65 |
—
| 267.75K |
Nov 2
|
Scheduled
| ||||||
Bridgebio Pharma, Inc.
|
0
|
$19.81 | -$380,348.18 |
—
| 267.75K |
Oct 1
|
Scheduled
| ||||||
Bridgebio Pharma, Inc.
|
0
|
$20.11 | -$397,788.12 |
—
| 267.75K |
Sep 18
|
Scheduled
| ||||||
Bridgebio Pharma, Inc.
|
0
|
$14.45 | -$285,734.39 |
—
| 267.75K |
Sep 1
|
Scheduled
| ||||||
Bridgebio Pharma, Inc.
| 7.35K |
$28.53 | -$155,773.80 | +2.82% | 267.75K |
Aug 16
| |||||||
Bridgebio Pharma, Inc.
|
0
|
$13.77 | -$272,140.73 |
—
| 260.29K |
Aug 3
|
Scheduled
| ||||||
Bridgebio Pharma, Inc.
|
0
|
$15.57 | -$308,101.26 |
—
| 260.29K |
Jul 1
|
Scheduled
| ||||||
Bridgebio Pharma, Inc.
| -606.00 |
$30.01 | -$18,185.25 | -0.23% | 260.29K |
Jun 8
|
Scheduled
| ||||||
Bridgebio Pharma, Inc.
| -2.58K |
$29.37 | -$75,911.65 | -0.98% | 261.68K |
Jun 1
|
Scheduled
| ||||||
Bridgebio Pharma, Inc.
| 18.36K |
$1.05 | $19,283.25 | +7.47% | 264.27K |
May 26
| |||||||
Bridgebio Pharma, Inc.
| 83.54K |
—
|
—
| +51.45% | 245.9K |
May 19
| |||||||
Bridgebio Pharma, Inc.
| -1.46K |
$30.47 | -$44,493.35 | -0.89% | 162.36K |
May 5
|
Scheduled
| ||||||
Bridgebio Pharma, Inc.
| -3.90K |
$29.52 | -$115,266.78 | -2.33% | 163.82K |
May 1 - May 4
|
Scheduled
| ||||||
Bridgebio Pharma, Inc.
| -2.58K |
$26.94 | -$69,629.23 | -1.52% | 167.73K |
Apr 1
|
Scheduled
| ||||||
Bridgebio Pharma, Inc.
| -3.98K |
$32.44 | -$128,965.21 | -2.28% | 170.31K |
Mar 2
|
Scheduled
| ||||||
Bridgebio Pharma, Inc.
| -3.98K |
$34.90 | -$138,729.49 | -2.23% | 174.29K |
Feb 3
|
Scheduled
| ||||||
Bridgebio Pharma, Inc.
| -3.98K |
$33.17 | -$131,861.08 | -2.18% | 178.26K |
Jan 2 - Jan 3
|
Scheduled
| ||||||
Bridgebio Pharma, Inc.
| 180.77K |
$17.00 |
—
|
∞
| 180.77K |
Jul 1
| |||||||
Bridgebio Pharma, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. | |||||||||||||
Want to view more results?
Unlock the hidden results with your Benzinga Account now. No purchase required.